Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Jazz Pharmaceuticals plc. A complete text table follows the diagram.
Product sales are the engine, with royalties and contract revenue completing Jazz's specialty-pharma model.
Swipe to explore
Labels and displayed flow values are reported filing values or exact disclosed subtotals.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Jazz Pharmaceuticals plc revenue | 1 | $1.1B | $1,068.9M reported quarterly revenue |
| Product sales, net | 2 | $1.0B | 96% of total revenues |
| Royalties and contract revenues | 2 | $43.6M | 4% of total revenues |
| From | To | Value |
|---|---|---|
| Jazz Pharmaceuticals plc revenue | Product sales, net | $1.0B |
| Jazz Pharmaceuticals plc revenue | Royalties and contract revenues | $43.6M |